1. D. W. Buck, J. W. Larrick, A. Raubitschek, K. Truitt, G. Senyk, J. Wang, and B. J. Dyer, Production of human monoclonal antibodies, in: “Monoclonal Antibodies and Functional Cell Lines,” R. H. Kennett, K. Bectol, and T. J. McKearn, eds., Plenum Press, New York (1984).
2. L. Chedid, M. Parant, F. Parant, and F. Boyer, A proposed mechanism for natural immunity to enterobacterial pathogens, J. Immunol. 100: 292 (1968).
3. C. E. Davis, E. J. Ziegler, and K. F. Arnold, Neutralization of meningococcal endotoxin by antibody to core glycolipid, Exp. Med. 1007 (1978).
4. D. L. Dunn and R. M. Ferguson, Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5, Surgery 92: 212 (1982).
5. S. K. H. Foung, S. Perkins, A. Raubitschek, J. Larrick, G. Lizak, D. Fishwild, E. G. Engleman, and F. C. Grumet, Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a mouse/human hybridoma, J. Immunol. Meth. 70: 83 (1984).